Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870492 · ClinicalTrials.gov registry record
Improving Patient Access to Stroke Therapy Study
A clinical trial, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- 500
- Enrollment target
NCT01870492 is a clinical trial that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 500 participants.
The verdict
NCT01870492 was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- 500 participants
- Enrollment target
Study Summary
Limited access is a major hurdle in the treatment of AIS; many hospitals, especially rural hospitals, do not have the infrastructure or medical support to effectively treat AIS patients.5 Failure to recognize the signs and symptoms of stroke by the patient and/or emergency medical services (EMS) is another barrier to the timely treatment of AIS. Several studies, including the Paul Coverdell National Acute Stroke Registry (PCNASR), have reported low rates of adherence to stroke care guidelines, suggesting that many AIS patients do not receive proper treatment according to established guidelines. Thus, there remains an increasing need to assess and address the barriers that prevent patient access to proper AIS treatment. Annually, approximately 20,000 patients are discharged from Wisconsin hospitals with the diagnosis of stroke and an estimated 4,000 patients die from stroke each year in WI. To date, there have been no statewide studies initiated in Wisconsin to assess the regional barriers to the treatment of AIS patients with thrombolytic or endovascular therapy, and many hospitals do not routinely collect and analyze AIS patient data. The goal of the Improving Patient Access to Stroke Therapy (IMPACT) pilot study is to engage community hospitals statewide to identify the regional barriers to AIS therapy in WI.
Interventions
- DRUG Activase
- DEVICE Endovascular therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01870492
The ClinicalTrials.gov registry entry for NCT01870492 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Activase is the first listed.
NCT01870492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01870492 about?
NCT01870492 is a clinical study titled "Improving Patient Access to Stroke Therapy Study". Limited access is a major hurdle in the treatment of AIS; many hospitals, especially rural hospitals, do not have the infrastructure or medical support to effectively treat AIS patients.5 Failure to recognize the signs and symptoms of stroke by the patient and/or emergency medical services (EMS) is ...
What is the current status of trial NCT01870492?
This trial is currently terminated. The enrollment target is 500 participants. The study started on 2014-01. Estimated completion is 2015-09-29.
What interventions are being tested in trial NCT01870492?
The interventions under investigation include: Activase (DRUG), Endovascular therapy (DEVICE).
Who is sponsoring clinical trial NCT01870492?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.